Loading company…
Palo Alto-based Open Monoclonal Technology generates human monoclonal antibodies using transgenic rats.
Founded in 2007 and based in California, US, Open Monoclonal Technology, Inc. provides biotechnology products and services that generate human monoclonal antibodies based on transgenic rats. The directory lists the company at the Series B stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in